MYTELASE Side Effects

6968676-2 | Atrioventricular Block, Cardiac Arrest
on Aug 27, 2010 Male patient from FRANCE , 58 years of age, was treated with Mytelase (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block, cardiac arrest (What is cardiac arrest?). Mytelase dosage: . Patient was hospitalized.

6968671-3 | Cholinergic Syndrome
Patient was taking Mytelase (View Usage). Patient had the following side effects: cholinergic syndrome on Aug 25, 2010 from JAPAN Additional patient health information: Male patient , 45 years of age, weighting 164.5 lb, was diagnosed with myasthenia gravis, hypertension, renal cell carcinoma and. Mytelase dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LAC B (View Lac B Review and Lac B Label ), DEPAS (View Depas Review and Depas Label ), SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ). Patient was hospitalized.

6880224-4 | Acute Respiratory Failure
Adverse event was reported on Jul 14, 2010 by a Male patient taking Mytelase (View Usage) (Dosage: ) was diagnosed with myasthenia gravis, hypertension, renal cell carcinoma and. Location: JAPAN , 45 years of age, weighting 164.5 lb, After Mytelase was administered, patient had the following side effects: acute respiratory failure. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LAC B (View Lac B Review and Lac B Label ), DEPAS (View Depas Review and Depas Label ), SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ). Patient was hospitalized.

6299639-0 | Dyskinesia, Dysphagia, Fatigue, Product Quality Issue
on Jul 03, 2009 Female patient from FRANCE , weighting 154.3 lb, was diagnosed with muscular weakness and was treated with Mytelase (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, dysphagia, fatigue, product quality issue. Mytelase dosage: . During the same period patient was treated with MESTINON (View Mestinon Review and Mestinon Label ), DAFALGAN (3 Df) (View Dafalgan Review and Dafalgan Label ), CHONDROSULT (View Chondrosult Review and Chondrosult Label ), ATARAX (2 Df) (View Atarax Review and Atarax Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).


6249885-7 | Dyskinesia, Dysphagia, Product Quality Issue
on Jun 17, 2009 Female patient from FRANCE , 67 years of age, was diagnosed with muscular weakness and was treated with Mytelase (View Usage). Patient had the following side effects: dyskinesia, dysphagia, product quality issue. Mytelase dosage: Unk. During the same period patient was treated with MESTINON (View Mestinon Review and Mestinon Label ).

6204641-0 | Caesarean Section, Overdose, Respiratory Depression
Patient was taking Mytelase (View Usage). After Mytelase was administered, patient had the following side effects: caesarean section, overdose, respiratory depression on May 18, 2009 from FRANCE Additional patient health information: Female patient , 27 years of age, was diagnosed with muscular weakness and. Mytelase dosage: Unk. Patient was hospitalized.

6030274-5 | Cholinergic Syndrome, Convulsion, Diarrhoea, Miosis, Overdose, Vomiting
Adverse event was reported on Dec 29, 2008 by a Female patient taking Mytelase (View Usage) (Dosage: 2 Mg) was diagnosed with myasthenic syndrome and. Location: FRANCE , weighting 8.82 lb, Patient experienced the following unwanted or unexpected effects: cholinergic syndrome, convulsion, diarrhoea, miosis, overdose, vomiting. During the same period patient was treated with PERFALGAN (Unk) (View Perfalgan Review and Perfalgan Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), PHOCYTAN (Unk) (View Phocytan Review and Phocytan Label ), UVESTEROL (Unk) (View Uvesterol Review and Uvesterol Label ).

5840480-8 | Brugada Syndrome, Bundle Branch Block Right, Electrocardiogram St Segment Elevation, Loss Of Consciousness, Ventricular Extrasystoles, Ventricular Fibrillation
on Jul 30, 2008 Male patient from JAPAN , 55 years of age, was diagnosed with muscular weakness and was treated with Mytelase (View Usage). Patient had the following side effects: brugada syndrome, bundle branch block right, electrocardiogram st segment elevation, loss of consciousness, ventricular extrasystoles, ventricular fibrillation. Mytelase dosage: 20 Mg. Patient was hospitalized.

5746907-4 | Abdominal Pain, Pancreatitis
on May 13, 2008 Male patient from JAPAN , 67 years of age, was diagnosed with myasthenia gravis and was treated with Mytelase (View Usage). After Mytelase was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), pancreatitis. Mytelase dosage: 20 Mg. During the same period patient was treated with PYRIDOSTIGMINE BROMIDE (180 Mg) (View Pyridostigmine Bromide Review and Pyridostigmine Bromide Label ). Patient was hospitalized.

5740221-9 | Abdominal Pain, Pancreatitis
Patient was taking Mytelase (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), pancreatitis on May 05, 2008 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with myasthenia gravis and. Mytelase dosage: 20 Mg. During the same period patient was treated with PYRIDOSTIGMINE BROMIDE (180 Mg) (View Pyridostigmine Bromide Review and Pyridostigmine Bromide Label ). Patient was hospitalized.

5618895-2 | Back Pain, Malaise, Movement Disorder, Muscle Spasms, Pain In Extremity, Posture Abnormal, Speech Disorder, Vertigo
Adverse event was reported on Aug 17, 2007 by a Female patient taking Mytelase (View Usage) (Dosage: 30 Mg) . Location: FRANCE , 43 years of age, Patient had the following side effects: back pain (What is back pain?), malaise, movement disorder (What is movement disorder?), muscle spasms, pain in extremity, posture abnormal, speech disorder, vertigo. Patient was hospitalized.

5422002-9 | Bronchopulmonary Aspergillosis
on Aug 17, 2007 Male patient from JAPAN , 76 years of age, weighting 101.4 lb, was diagnosed with myasthenia gravis, hypertension, oral candidiasis, urine output decreased, gastric ulcer, delirium and was treated with Mytelase (View Usage). After Mytelase was administered, patient had the following side effects: bronchopulmonary aspergillosis. Mytelase dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), RENIVACE (View Renivace Review and Renivace Label ), ARTIST (View Artist Review and Artist Label ), FLORID (View Florid Review and Florid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), NEORAL (300 Mg, Qd) (View Neoral Review and Neoral Label ).

5404816-4 | Bronchopulmonary Aspergillosis
on Jul 27, 2007 Male patient from JAPAN , 76 years of age, weighting 101.4 lb, was diagnosed with myasthenia gravis, hypertension, oral candidiasis, urine output decreased, gastric ulcer, delirium and was treated with Mytelase (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis. Mytelase dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ARTIST (View Artist Review and Artist Label ), FLORID (View Florid Review and Florid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), NEORAL (300 Mg, Qd) (View Neoral Review and Neoral Label ).

4917784-6 | Abortion Induced, Foetal Malformation
Patient was taking Mytelase (View Usage). Patient had the following side effects: abortion induced, foetal malformation on Dec 09, 2005 from FRANCE Additional patient health information: Female patient , 33 years of age, was diagnosed with myasthenic syndrome and. Mytelase dosage: Unk. During the same period patient was treated with PAROXETINE HCL (Unk) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), VITAMIN B 12 (Unk) (View Vitamin B-12 Review and Vitamin B-12 Label ).

4893614-6 | Abortion Induced, Foetal Malformation, Lymphoedema, Skull Malformation
Adverse event was reported on Dec 09, 2005 by a Female patient taking Mytelase (View Usage) (Dosage: Unk) was diagnosed with myasthenic syndrome and. Location: FRANCE , 33 years of age, After Mytelase was administered, patient had the following side effects: abortion induced, foetal malformation, lymphoedema, skull malformation. During the same period patient was treated with PAROXETINE HCL (Unk) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), VITAMIN B 12 (Unk) (View Vitamin B-12 Review and Vitamin B-12 Label ).

4827488-6 | Cardio-respiratory Arrest, Cerebral Disorder, Cholinergic Syndrome, Pain
on Nov 02, 2005 Female patient from FRANCE , 39 years of age, weighting 158.7 lb, was diagnosed with myasthenic syndrome and was treated with Mytelase (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, cerebral disorder, cholinergic syndrome, pain (What is pain?). Mytelase dosage: .

4608968-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Thymectomy
on Jan 21, 2005 Male patient from , 56 years of age, was diagnosed with myasthenia gravis and was treated with Mytelase (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, thymectomy. Mytelase dosage: 20mg Po. During the same period patient was treated with CAPROCIN INJ. (HEPARIN CALCIUM) (View Caprocin Inj. (heparin Calcium) Review and Caprocin Inj. (heparin Calcium) Label ), BAYASPIRIN (ASPIRIN) (View Bayaspirin (aspirin) Review and Bayaspirin (aspirin) Label ). Patient was hospitalized.